The burden of diseases and risk factors in Bangladesh, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019
Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved..
BACKGROUND: Bangladesh has made substantial progress in improving socioeconomic and health indicators over the past 50 years, but data on national disease burden are scarce. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to estimate the burden of diseases and risk factors in Bangladesh from 1990 to 2019.
METHODS: For this systematic analysis, we analysed data from vital registration systems, surveys, and censuses using multistage modelling processes to estimate life expectancy at birth, mortality rate, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). Additionally, we compared the health status of Bangladesh with that of the other countries in the GBD south Asia region-Bhutan, India, Nepal, and Pakistan.
FINDINGS: Life expectancy at birth in Bangladesh increased from 58·2 years (95% uncertainty interval 57·1-59·2) in 1990 to 74·6 years (72·4-76·7) in 2019. Between 1990 and 2019, the age-standardised mortality rate decreased from 1509·3 (1428·6-1592·1) to 714·4 (604·9-838·2) deaths per 100 000 population. In 2019, non-communicable diseases represented 14 of the top 20 causes of death; the leading three causes were stroke, ischaemic heart disease, and chronic obstructive pulmonary disease. High blood pressure, high fasting plasma glucose, and smoking were the top three risk factors. From 1990 to 2019, the rate of all-cause DALYs decreased by 54·9% (48·8-60·4). In 2019, the leading causes of DALYs and YLLs were neonatal disorders, stroke, and ischaemic heart disease, whereas musculoskeletal disorders, depressive disorders, and low back pain were the leading causes of YLDs. Bangladesh has the lowest age-standardised rates of mortality, YLDs, and YLLs and the highest life expectancy at birth in south Asia.
INTERPRETATION: Over the past 30 years, mortality rates have reduced by more than half in Bangladesh. Bangladesh must now address the double burden of communicable and non-communicable diseases. Cost-effective, multisectoral efforts are needed to prevent and control non-communicable diseases, promote healthy lifestyles, and prevent premature mortality and disabilities.
FUNDING: Bill & Melinda Gates Foundation.
TRANSLATION: For the Bangla translation of the abstract see Supplementary Materials section.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
The Lancet. Global health - 11(2023), 12 vom: 16. Dez., Seite e1931-e1942 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GBD 2019 Bangladesh Burden of Disease Collaborators [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.11.2023 Date Revised 27.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/S2214-109X(23)00432-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364649054 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364649054 | ||
| 003 | DE-627 | ||
| 005 | 20231226095853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2214-109X(23)00432-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1215.xml |
| 035 | |a (DE-627)NLM364649054 | ||
| 035 | |a (NLM)37973341 | ||
| 035 | |a (PII)S2214-109X(23)00432-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GBD 2019 Bangladesh Burden of Disease Collaborators |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The burden of diseases and risk factors in Bangladesh, 1990-2019 |b a systematic analysis for the Global Burden of Disease Study 2019 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.11.2023 | ||
| 500 | |a Date Revised 27.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a BACKGROUND: Bangladesh has made substantial progress in improving socioeconomic and health indicators over the past 50 years, but data on national disease burden are scarce. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to estimate the burden of diseases and risk factors in Bangladesh from 1990 to 2019 | ||
| 520 | |a METHODS: For this systematic analysis, we analysed data from vital registration systems, surveys, and censuses using multistage modelling processes to estimate life expectancy at birth, mortality rate, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). Additionally, we compared the health status of Bangladesh with that of the other countries in the GBD south Asia region-Bhutan, India, Nepal, and Pakistan | ||
| 520 | |a FINDINGS: Life expectancy at birth in Bangladesh increased from 58·2 years (95% uncertainty interval 57·1-59·2) in 1990 to 74·6 years (72·4-76·7) in 2019. Between 1990 and 2019, the age-standardised mortality rate decreased from 1509·3 (1428·6-1592·1) to 714·4 (604·9-838·2) deaths per 100 000 population. In 2019, non-communicable diseases represented 14 of the top 20 causes of death; the leading three causes were stroke, ischaemic heart disease, and chronic obstructive pulmonary disease. High blood pressure, high fasting plasma glucose, and smoking were the top three risk factors. From 1990 to 2019, the rate of all-cause DALYs decreased by 54·9% (48·8-60·4). In 2019, the leading causes of DALYs and YLLs were neonatal disorders, stroke, and ischaemic heart disease, whereas musculoskeletal disorders, depressive disorders, and low back pain were the leading causes of YLDs. Bangladesh has the lowest age-standardised rates of mortality, YLDs, and YLLs and the highest life expectancy at birth in south Asia | ||
| 520 | |a INTERPRETATION: Over the past 30 years, mortality rates have reduced by more than half in Bangladesh. Bangladesh must now address the double burden of communicable and non-communicable diseases. Cost-effective, multisectoral efforts are needed to prevent and control non-communicable diseases, promote healthy lifestyles, and prevent premature mortality and disabilities | ||
| 520 | |a FUNDING: Bill & Melinda Gates Foundation | ||
| 520 | |a TRANSLATION: For the Bangla translation of the abstract see Supplementary Materials section | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Islam, Sheikh Mohammed Shariful |e investigator |4 oth | |
| 700 | 1 | |a Uddin, Riaz |e investigator |4 oth | |
| 700 | 1 | |a Das, Subasish |e investigator |4 oth | |
| 700 | 1 | |a Ahmed, Syed Imran |e investigator |4 oth | |
| 700 | 1 | |a Zaman, Sojib Bin |e investigator |4 oth | |
| 700 | 1 | |a Alif, Sheikh Mohammad |e investigator |4 oth | |
| 700 | 1 | |a Hossen, Md Tanvir |e investigator |4 oth | |
| 700 | 1 | |a Sarker, Malabika |e investigator |4 oth | |
| 700 | 1 | |a Siopis, George |e investigator |4 oth | |
| 700 | 1 | |a Livingstone, Katherine M |e investigator |4 oth | |
| 700 | 1 | |a Mehlman, Max L |e investigator |4 oth | |
| 700 | 1 | |a Rahman, Md Marufur |e investigator |4 oth | |
| 700 | 1 | |a Chowdhury, Rahat I |e investigator |4 oth | |
| 700 | 1 | |a Alim, Md Abdul |e investigator |4 oth | |
| 700 | 1 | |a Choudhury, Sohel Reza |e investigator |4 oth | |
| 700 | 1 | |a Ahmed, Syed Masud |e investigator |4 oth | |
| 700 | 1 | |a Adhikary, Ripon Kumar |e investigator |4 oth | |
| 700 | 1 | |a Anjum, Afifa |e investigator |4 oth | |
| 700 | 1 | |a Banik, Palash Chandra |e investigator |4 oth | |
| 700 | 1 | |a Chowdhury, Fazle Rabbi |e investigator |4 oth | |
| 700 | 1 | |a Faruk, Md Omar |e investigator |4 oth | |
| 700 | 1 | |a Gupta, Rajat Das |e investigator |4 oth | |
| 700 | 1 | |a Hannan, Md Abdul |e investigator |4 oth | |
| 700 | 1 | |a Haque, Md Nuruzzaman |e investigator |4 oth | |
| 700 | 1 | |a Haque, Syed Emdadul |e investigator |4 oth | |
| 700 | 1 | |a Hasan, M Tasdik |e investigator |4 oth | |
| 700 | 1 | |a Hossain, Md Belal |e investigator |4 oth | |
| 700 | 1 | |a Hossain, Md Mahbub |e investigator |4 oth | |
| 700 | 1 | |a Hossain, Muttaquina |e investigator |4 oth | |
| 700 | 1 | |a Hossain, Sahadat |e investigator |4 oth | |
| 700 | 1 | |a Hossain, Sheikh Jamal |e investigator |4 oth | |
| 700 | 1 | |a Khan, M Nuruzzaman |e investigator |4 oth | |
| 700 | 1 | |a Khan, Md Jobair |e investigator |4 oth | |
| 700 | 1 | |a Mamun, Mohammed A |e investigator |4 oth | |
| 700 | 1 | |a Mokdad, Ali H |e investigator |4 oth | |
| 700 | 1 | |a Moni, Mohammad Ali |e investigator |4 oth | |
| 700 | 1 | |a Murray, Christopher J L |e investigator |4 oth | |
| 700 | 1 | |a Rahman, Mahfuzar |e investigator |4 oth | |
| 700 | 1 | |a Rahman, Md Mosfequr |e investigator |4 oth | |
| 700 | 1 | |a Rahman, Mosiur |e investigator |4 oth | |
| 700 | 1 | |a Ratan, Zubair Ahmed |e investigator |4 oth | |
| 700 | 1 | |a Ripon, Rezaul Karim |e investigator |4 oth | |
| 700 | 1 | |a Saif-Ur-Rahman, K M |e investigator |4 oth | |
| 700 | 1 | |a Sayeed, Abu |e investigator |4 oth | |
| 700 | 1 | |a Siraj, Md Shahjahan |e investigator |4 oth | |
| 700 | 1 | |a Sultana, Saima |e investigator |4 oth | |
| 700 | 1 | |a Maddison, Ralph |e investigator |4 oth | |
| 700 | 1 | |a Hay, Simon I |e investigator |4 oth | |
| 700 | 1 | |a Naghavi, Mohsen |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Global health |d 2013 |g 11(2023), 12 vom: 16. Dez., Seite e1931-e1942 |w (DE-627)NLM237515954 |x 2214-109X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g number:12 |g day:16 |g month:12 |g pages:e1931-e1942 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2214-109X(23)00432-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2023 |e 12 |b 16 |c 12 |h e1931-e1942 | ||